This discrepancy in HER2 amplification incidence is consistent with the demographic variation noted in our study, with Asian patients with CRC demonstrating higher HER2 amplification rates (3.9%) compared to Black and White patients with CRC (3.0% and 2.7%, respectively). The gene discussed is ERBB2; the disease is colorectal carcinoma.